当前位置:首页 - 行情中心 - *ST生物(000504) - 财务分析

*ST生物

(000504)

  

流通市值:22.55亿  总市值:23.96亿
流通股本:3.11亿   总股本:3.30亿

*ST生物(000504)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.07亿元,每股收益-0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益27524.29万元,未分配利润-55316.52万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产60191.49万元,负债32667.20万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入22,453,576.28134,447,796.8592,417,062.8756,324,793.65
营业总成本30,056,727.81137,824,949.6995,167,473.4962,125,483.17
营业利润-5,553,969.06-20,814,004.11-7,456,617.55-11,059,226.87
利润总额-5,932,683.47-20,851,607.18-7,475,250.54-11,065,820.55
净利润-6,522,060.18-23,925,602.31-8,885,815.36-11,629,172.38
其他综合收益----
综合收益总额-6,522,060.18-23,925,602.31-8,885,815.36-11,629,172.38
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计389,870,377.5401,904,309.43492,882,061.82472,210,483.31
非流动资产合计212,044,484.84206,265,508.54101,204,967.07107,352,659.86
资产总计601,914,862.34608,169,817.97594,087,028.89579,563,143.17
流动负债合计304,625,223.16305,471,086.7269,112,521.13274,537,654.81
非流动负债合计22,046,761.8520,700,624.0323,770,416.9412,230,792.48
负债合计326,671,985.01326,171,710.73292,882,938.07286,768,447.29
归属于母公司股东权益合计234,876,547.76237,095,180.02248,647,127.8248,548,368.09
股东权益合计275,242,877.33281,998,107.24301,204,090.82292,794,695.88
负债和股东权益合计601,914,862.34608,169,817.97594,087,028.89579,563,143.17
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计48,307,611.33242,007,634.36135,464,797.3979,259,351.23
经营活动现金流出小计49,132,903.6237,214,051.51128,547,172.4977,407,363.52
经营活动产生的现金流量净额-825,292.274,793,582.856,917,624.91,851,987.71
投资活动现金流入小计1,583,303.14201,029,852.39223,029,733.17206,384,284
投资活动现金流出小计65,226,890309,362,796.78328,548,828.94307,506,920.91
投资活动产生的现金流量净额-63,643,586.86-108,332,944.39-105,519,095.77-101,122,636.91
筹资活动现金流入小计-18,000,00018,000,0008,000,000
筹资活动现金流出小计1,488,371.69200,908,607.52198,471,647.76198,000,571.5
筹资活动产生的现金流量净额-1,488,371.69-182,908,607.52-180,471,647.76-190,000,571.5
汇率变动对现金及现金等价物的影响-40.5916.9316.93
现金及现金等价物净增加额-65,957,250.82-286,447,928.47-279,073,101.7-289,271,203.77
期末现金及现金等价物余额141,375,896.11207,333,146.93214,707,973.7204,509,871.63
TOP↑